Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Slowing Down Stock

677.3000 21.85 (3.33%)

NSE Mar 20, 2026 15:47 PM

New 52W Low in past week

Volume: 70,386

Alembic Pharmaceuticals Ltd.

12 Jan 2026

677.30

3.33%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals Limited announces USFDA Tentative approval for Bosutinib Tablets, 400 mg.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market closes higher as oil prices ease slightly amid signs of restraint from the US and Israel

Trendlyne Marketwatch | 20 Mar 2026, 03:57PM

Superstar investors pay the price for crowded bets

The Baseline | 19 Mar 2026, 05:45PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals